SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
76.80    2.00 (2.67%)
Bid:
76.80
Ask:
76.86
Spread: 0.06 (0.078%)
Market Cap: £2.67b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

11 Jan 2024 07:00

RNS Number : 3171Z
Taylor Wimpey PLC
11 January 2024
 

 

 

11 January 2024

Taylor Wimpey plc

Trading statement for the year ended 31 December 2023

Taylor Wimpey is issuing the following update on trading ahead of its full year results for the year ended 31 December 2023, which will be announced on 28 February 2024.

 

 

Group operating profit expected to be at the top end of our guidance range

 

Jennie Daly, CEO, commented:

"We are pleased to have delivered a full year performance in line with expectations and expect to report full year operating profit* at the top end of our guidance range. Despite the difficult market conditions throughout the year, we maintained a sharp operational focus and delivered a good performance.

Looking ahead, it is encouraging to see a reduction in mortgage rates, however, in the short term the market remains uncertain and the planning backdrop extremely challenging.

Taylor Wimpey is a strong and agile business underpinned by a robust balance sheet and an excellent, well-located landbank. These attributes enable us to manage the business in all market conditions, delivering quality homes to our customers and long term value to our stakeholders. We remain confident in the attractive medium and long term fundamentals of the sector."

 

2023 performance

Total Group completions (including joint ventures) were 10,848 (2022: 14,154). UK home completions (including joint ventures) were 10,438? (2022: 13,773), which included 2,388 affordable homes (2022: 2,920) equating to 23% of total completions (2022: 21%). Our net private reservation rate for 2023 was 0.62 homes per outlet per week (2022: 0.68). Excluding the impact of bulk deals, the net private sales rate was 0.54 (2022: 0.65). The cancellation rate for the full year was 18% (2022: 18%).

UK average selling prices on private completions increased by 5.1% to £370k (2022: £352k) with the overall average selling price increasing by 3.5% to £324k (2022: £313k). We ended the year with a lower order book valued at £1,772 million (31 December 2022: £1,941 million), excluding joint ventures, which represents 6,999 homes (31 December 2022: 7,499 homes), of which 2,565 are private (2022: 2,943) and 4,434 are affordable (2022: 4,556).

In the UK, we traded from an average of 238 outlets in 2023 (2022: 232) and ended the year with a total of 237 outlets (31 December 2022: 259).

We continue to expect full year Group operating profit to be at the top end of our guidance range of £440 million to £470 million.

As expected, prevailing build cost inflation continued to moderate throughout H2 2023 and is now running at 0-1% on new tenders. We expect underlying build cost inflation of c.4% on H1 2024 completions as inflation contained in the opening work in progress balance is realised. 

Land and planning

As at 31 December 2023, our short term landbank stood at c.80k plots (2022: c.83k). Our strategic land pipeline was c.142k potential plots (2022: c.144k potential plots).

Our strong land position enabled us to continue to be highly selective in our land buying during the year and as a result, 2023 approvals were significantly lower, at c.3k plots (2022: c.7k).

The planning system remains slow and continues to impact outlet openings as material delays in planning and technical determinations persist. However, we have a high-quality, well-located landbank and our experienced teams continue to work hard to progress this land through planning.

Spain current trading

Our Spanish business performed well, completing 410 homes in the year (2022: 381) at an average selling price of ?400k (2022: ?383k). The total order book as at 31 December 2023 stood at 490 homes (31 December 2022: 448 homes).

Group cash position

We ended the year with a strong net cash? position of £678 million (31 December 2022: £864 million net cash).

Outlook

As previously guided, we enter the year with a reduced order book. Whilst too early in the year to gauge customer behaviour, we have seen good levels of enquiries so far this year and it is encouraging to see recent mortgage rate reductions which will improve affordability.

We will continue to focus on driving value and sales performance, maintaining tight control on costs and investment in work in progress.

The planning environment remains challenging and will continue to impact outlet openings. However, as we look ahead, with a strong balance sheet and a highly experienced management team, we remain well positioned to optimise our strong landbank and strategic pipeline and remain confident in the attractive medium and long term fundamentals of the sector.

 

* Operating profit is defined as profit on ordinary activities before financing, exceptional items, and tax, after share of results of joint ventures.

? Net cash is defined as total cash less total borrowings.

 

Note:

? Joint ventures completions were 82 in 2023 (2022: 222).

 

-Ends-

 

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 8.30am on 11 January 2024. The call will be recorded and streamed live to our website: www.taylorwimpey.co.uk/corporate/investors/results-and-reports

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

 

Notes to editors:

Taylor Wimpey plc is a customer-focused homebuilder, operating at a local level from 22 regional businesses across the UK. We also have operations in Spain.

For further information, please visit the Group's website: www.taylorwimpey.co.uk

Follow us on X via @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFFILRIILIS
Date   Source Headline
3rd Mar 20254:33 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:09 pmRNSTotal Voting Rights
28th Feb 20253:28 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSTAYLOR WIMPEY PLC FULL YEAR RESULTS
12th Feb 20252:47 pmRNSDirector/PDMR Shareholding
3rd Feb 20252:04 pmRNSTotal Voting Rights
27th Jan 20253:58 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Statement
10th Jan 202510:48 amRNSDirector/PDMR Shareholding
2nd Jan 20251:45 pmRNSBlock listing Interim Review
2nd Jan 20251:42 pmRNSBlock listing Interim Review
2nd Jan 20251:28 pmRNSTotal Voting Rights
19th Dec 20247:31 amRNSTransaction in Own Shares
13th Dec 20243:42 pmRNSDirector/PDMR Shareholding
10th Dec 20244:50 pmRNSDirector/PDMR Shareholding
4th Dec 20245:10 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
26th Nov 20243:22 pmRNSHolding(s) in Company
22nd Nov 202411:09 amRNSDirectorate Change
19th Nov 20243:32 pmRNSDirector/PDMR Shareholding
19th Nov 20243:03 pmRNSHolding(s) in Company
13th Nov 20243:32 pmRNSHolding(s) in Company
11th Nov 20242:58 pmRNSDirector/PDMR Shareholding
11th Nov 20242:39 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSTrading Statement
1st Nov 202410:08 amRNSTotal Voting Rights
9th Oct 20242:00 pmRNSDirector/PDMR Shareholding
1st Oct 20241:26 pmRNSTotal Voting Rights
26th Sep 20242:40 pmRNSDirector/PDMR Shareholding
20th Sep 202412:47 pmRNSHolding(s) in Company
10th Sep 20244:08 pmRNSDirector/PDMR Shareholding
2nd Sep 20243:30 pmRNSTotal Voting Rights
9th Aug 20242:36 pmRNSDirector/PDMR Shareholding
1st Aug 20242:57 pmRNSTotal Voting Rights
31st Jul 20247:05 amRNSBoard Committee Change
31st Jul 20247:00 amRNSHalf year results 2024
26th Jul 20243:22 pmRNSHolding(s) in Company
22nd Jul 20249:10 amRNSHolding(s) in Company
9th Jul 202411:26 amRNSDirector/PDMR Shareholding
1st Jul 20243:12 pmRNSTotal Voting Rights
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:29 amRNSBlock listing Interim Review
17th Jun 20243:18 pmRNSDirector/PDMR Shareholding
6th Jun 202411:22 amRNSHolding(s) in Company
3rd Jun 20249:17 amRNSTotal Voting Rights
30th May 20244:07 pmRNSDirector/PDMR Shareholding
17th May 20247:15 amRNSDirector/PDMR Shareholding
15th May 20241:09 pmRNSDirector/PDMR Shareholding
9th May 202411:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.